Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hamel

Showing results (281-290 of 292) with videos related to

Pageof 30
Sort By:
British Journal of Cancer|February 26, 2009
The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancerR Diaz, P A Nguewa, J A Diaz-Gonzalez, et al.
Molecular Pharmacology|February 17, 2001
Dolastatin 11, a marine depsipeptide, arrests cells at cytokinesis and induces hyperpolymerization of purified actinR Bai, P Verdier-Pinard, S Gangwar, et al.
Anti-Cancer Drug Design|May 21, 1999
Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrugG R Pettit, M R Rhodes, D L Herald, et al.
Journal of Natural Products|October 1, 1993
Two new cytotoxic chalcones from Calythropsis aureaJ A Beutler, J H Cardellina, G N Gray, et al.
Bioorganic & Medicinal Chemistry|September 11, 1999
Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. spongesW R Gamble, N A Durso, R W Fuller, et al.
Anti-Cancer Drug Design|October 1, 1995
Antineoplastic agents 337. Synthesis of dolastatin 10 structural modificationsG R Pettit, J K Srirangam, J Barkoczy, et al.
European Journal of Pharmacology|January 24, 1998
The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraineM A Petty, J Elands, M P Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Antitumor agents. Part 204: synthesis and biological evaluation of substituted 2-aryl quinazolinonesY Xia, Z Y Yang, M J Hour, et al.
Journal of Medicinal Chemistry|April 30, 1993
Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4'-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulinS C Kuo, H Z Lee, J P Juang, et al.
Molecular Pharmacology|January 28, 1998
Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cellsP Verdier-Pinard, J Y Lai, H D Yoo, et al.
Pageof 30

Showing results (281-290 of 292) with videos related to

Sort By:
Pageof 30
British Journal of Cancer|February 26, 2009
The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancerR Diaz, P A Nguewa, J A Diaz-Gonzalez, et al.
Molecular Pharmacology|February 17, 2001
Dolastatin 11, a marine depsipeptide, arrests cells at cytokinesis and induces hyperpolymerization of purified actinR Bai, P Verdier-Pinard, S Gangwar, et al.
Anti-Cancer Drug Design|May 21, 1999
Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrugG R Pettit, M R Rhodes, D L Herald, et al.
Journal of Natural Products|October 1, 1993
Two new cytotoxic chalcones from Calythropsis aureaJ A Beutler, J H Cardellina, G N Gray, et al.
Bioorganic & Medicinal Chemistry|September 11, 1999
Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. spongesW R Gamble, N A Durso, R W Fuller, et al.
Anti-Cancer Drug Design|October 1, 1995
Antineoplastic agents 337. Synthesis of dolastatin 10 structural modificationsG R Pettit, J K Srirangam, J Barkoczy, et al.
European Journal of Pharmacology|January 24, 1998
The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraineM A Petty, J Elands, M P Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Antitumor agents. Part 204: synthesis and biological evaluation of substituted 2-aryl quinazolinonesY Xia, Z Y Yang, M J Hour, et al.
Journal of Medicinal Chemistry|April 30, 1993
Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4'-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulinS C Kuo, H Z Lee, J P Juang, et al.
Molecular Pharmacology|January 28, 1998
Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cellsP Verdier-Pinard, J Y Lai, H D Yoo, et al.
Pageof 30